OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PTSM: Pharmaceutical Technology Sourcing and Management
August 04, 2014
Biopharma manufacturers must reduce the risk in their complex supply chains
Metrics Contract Services adopts a more descriptive name and brand that identifies it as being part of the Mayne Pharma global family.
API Synthesis & Manufacturing
The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.
More health systems are saying ?no? to reimbursements for new drugs; CMOs must adjust strategies.
Catalent?s $870 million IPO will help company reduce debt, enable future growth.
FDA's Secure Supply Chain Pilot Program, RX-360, and other industry efforts advance actions to secure the drug supply chain.
August 01, 2014
Hovione announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by FDA.
July 30, 2014
FDA issues a warning letter to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. and its import/export company for multiple CGMP violations and misbranded products.
July 29, 2014
Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at Mevisa, Spain.
SGS to add testing laboratories for biotechnology, extractables and leachables, and elemental impurities to Shanghai facility.
Packaging Coordinators, Inc. expands its services with acquisition of Penn Pharmaceutical Services.
Study provides first substantive reference data on key quality attributes of empty capsules
PrimePac tubes, part of the company's new portfolio of packaging, have been specifically designed with a safety zone to hold tablet punches in position to stop damage to the tip face.
July 22, 2014
Novasep gains approval from FDA to produce new molecular entity for US market.
July 16, 2014
West's new plant in India will manufacture primary packaging for injectable drugs.
Trifarma cited for significant deviations in data collection and security, and employee training.
July 09, 2014
Hospira acquires assets from Orchid Chemicals & Pharmaceuticals for $218 million.